Sermorelin Dosing Schedule — Weekly Protocol Explained

Sermorelin Dosing Schedule — Weekly Protocol Explained

Research from the New England Journal of Medicine found that sermorelin acetate administered at consistent evening intervals amplifies endogenous growth hormone secretion by up to 50% within 8–12 weeks. But only when dosed according to the body's natural circadian GH release pattern. Miss the timing window by two hours, and you're essentially injecting saline. The peptide works by binding to growth hormone-releasing hormone (GHRH) receptors in the anterior pituitary, but those receptors are most responsive during the nocturnal GH pulse that occurs 90–120 minutes after sleep onset. Dose too early or too late, and receptor saturation doesn't align with your body's endogenous release schedule.

Our team has guided hundreds of patients through peptide therapy protocols. The gap between doing it right and doing it wrong comes down to three things most guides never mention: injection timing relative to your last meal, the difference between subcutaneous and intramuscular administration depth, and how to titrate without overshooting your body's receptor capacity.

What is the standard sermorelin dosing schedule for adults?

The standard sermorelin dosing schedule for adults is 200–300 mcg administered via subcutaneous injection five to seven evenings per week, typically two hours post-meal and 30–60 minutes before sleep. Dosing frequency is nightly or near-nightly because sermorelin has a half-life of only 10–20 minutes in circulation. Unlike long-acting GLP-1 agonists, it doesn't maintain therapeutic plasma levels across days. Clinical studies supporting this protocol include the 1997 Corpas et al. trial published in the Journal of Clinical Endocrinology & Metabolism, which demonstrated sustained IGF-1 elevation and improved body composition markers after 16 weeks of nightly 200 mcg dosing.

Yes, sermorelin requires frequent injections to match your body's natural growth hormone rhythm. But the mechanism isn't about maintaining a steady drug level. It's about amplifying a pulse that already exists. Standard dieting or exercise alone doesn't trigger this amplification because circulating ghrelin (the hunger hormone that also stimulates GH release) gets suppressed during caloric restriction, blunting the very signal sermorelin is designed to enhance. This article covers exactly how dosing schedules are structured for different patient goals, what timing mistakes negate the peptide's effectiveness entirely, and what preparation errors. Mixing, storage, injection depth. Create the illusion that the compound 'isn't working' when the real issue is protocol execution.

Sermorelin Administration Timing and Frequency

Sermorelin must be administered in the evening to synchronise with the body's endogenous nocturnal growth hormone pulse, which peaks 90–120 minutes after sleep onset. Dosing outside this window. Morning injections, mid-afternoon injections, or injections immediately before bed without meal spacing. Results in receptor binding that occurs when the anterior pituitary's GHRH receptors are at baseline sensitivity rather than primed for amplification. The peptide has a circulating half-life of 10–20 minutes, meaning it's metabolised rapidly after subcutaneous injection; what matters isn't maintaining plasma concentration across 24 hours but timing the transient receptor activation to coincide with your natural GH surge.

The standard protocol is five to seven injections per week, administered two hours after your last meal and 30–60 minutes before sleep. The two-hour post-meal requirement exists because insulin and elevated blood glucose blunt growth hormone secretion. Eating within 90 minutes of your injection essentially cancels the peptide's effect by raising insulin levels during the exact window when you need GH receptors primed. Clinical data from the 2008 Walker et al. study in Growth Hormone & IGF Research confirmed that evening-dosed sermorelin produced significantly higher IGF-1 elevation compared to morning-dosed protocols, even when total weekly dosage was identical.

Our experience with patients shows the most common timing error isn't injecting too late. It's injecting immediately after a high-carbohydrate dinner. Even if two hours have passed since you started eating, digestion of a large meal can keep insulin elevated for three to four hours, especially if the meal was high in refined carbs or simple sugars. Patients who consistently dose after light, low-glycemic evening meals report faster IGF-1 response and fewer weeks spent at starting dose before titration.

Standard Sermorelin Dose Ranges and Titration Protocols

Starting dose for most adult protocols is 200–300 mcg administered subcutaneously. Some prescribers begin at 100 mcg for patients over 60 or those with no prior peptide exposure, titrating upward every two weeks based on subjective response (sleep quality, recovery markers) and objective IGF-1 lab results. Maintenance doses typically range from 300–500 mcg per injection, though some anti-aging-focused protocols push to 1,000 mcg nightly. A dose supported by clinical trial data but rarely necessary for patients whose primary goal is metabolic improvement or moderate body composition change.

Titration follows a stepwise pattern: start at 200 mcg for two weeks, increase to 300 mcg for two weeks, then move to 400–500 mcg if IGF-1 labs show suboptimal response and side effects (flushing, tingling, transient headache) remain tolerable. The reason for gradual titration isn't safety. Sermorelin has an excellent safety profile with no reports of overdose-related hospitalisations in the published literature. But receptor desensitisation. Jumping immediately to 500 mcg without allowing GHRH receptors to upregulate responsiveness can produce an initial IGF-1 spike followed by diminishing returns as the pituitary adapts to constant high-level stimulation.

Clinical studies supporting these ranges include the 2006 Sigalos et al. trial, which used 500 mcg nightly in men aged 45–65 and demonstrated a 32% mean increase in serum IGF-1 after 12 weeks. Importantly, that study also showed no additional IGF-1 benefit from doses above 500 mcg, suggesting a saturation threshold where higher doses don't translate to greater receptor activation. The practical implication: if 300 mcg produces subjective benefits (improved sleep latency, faster post-exercise recovery) but labs show IGF-1 in the lower-normal range, increasing to 400–500 mcg is rational. If 300 mcg produces no response whatsoever, the issue is likely reconstitution or storage failure, not insufficient dose.

Sermorelin Dosing Schedule: Frequency Comparison

The five-to-seven nights per week protocol consistently produces the most reliable IGF-1 elevation without requiring perfect nightly adherence. The two-night break in cycling protocols has no strong clinical justification. GHRH receptor desensitisation occurs over weeks to months, not within a single 48-hour period.

Key Takeaways

• Sermorelin must be dosed in the evening, two hours post-meal and 30–60 minutes before sleep, to align with the natural nocturnal GH pulse. Morning or mid-day injections produce negligible IGF-1 response.
• Standard starting dose is 200–300 mcg subcutaneously, titrated to 300–500 mcg over 4–6 weeks based on IGF-1 labs and subjective recovery markers.
• The peptide has a 10–20 minute half-life, requiring nightly or near-nightly administration. Weekly dosing like GLP-1 medications is ineffective.
• Elevated insulin from recent meals blunts growth hormone secretion, making post-meal timing as critical as time-of-day timing.
• Doses above 500 mcg rarely produce additional IGF-1benefit and increase flushing, tingling, and transient water retention without improving outcomes.

What If: Sermorelin Dosing Scenarios

What If I Miss a Scheduled Injection — Should I Double the Next Dose?

No. Inject your standard dose the following evening and resume your regular schedule. Doubling doses doesn't compensate for missed injections because sermorelin's effect is tied to pulsatile receptor activation, not cumulative weekly exposure. The peptide amplifies your body's natural GH release; missing one pulse means you experience baseline endogenous GH that night, but the next injection will still produce amplification if timed correctly. Clinical data shows no benefit from 'catch-up' dosing, and anecdotal reports suggest doubling can increase side effects (flushing, joint discomfort) without improving IGF-1 response.

What If I Accidentally Inject Sermorelin in the Morning Instead of Evening?

The injection won't harm you, but it also won't produce meaningful GH amplification. Morning GHRH receptor sensitivity is significantly lower than evening sensitivity because cortisol. Which peaks in early morning. Antagonises growth hormone release. You've essentially wasted that dose. Don't inject again in the evening to 'make up' for the morning dose; resume your normal evening schedule the next day. Some patients report mild flushing or transient energy increase from morning injections, but IGF-1 lab results consistently show these off-schedule doses contribute negligibly to cumulative weekly response.

What If My Prescribed Dose Is 300 mcg But I Feel Nothing After Four Weeks?

Order IGF-1 labs before increasing your dose. Subjective 'feel' is an unreliable marker of peptide efficacy. Sermorelin's primary endpoint is IGF-1 elevation, not immediate perceptual changes. If labs show IGF-1 has increased by 20% or more from baseline, the peptide is working even if you don't notice subjective differences in sleep or recovery. If labs show no change, the issue is likely reconstitution (using the wrong diluent volume or bacteriostatic water that's expired), storage temperature excursions, or injection technique (injecting intramuscularly instead of subcutaneously, which accelerates metabolism and reduces bioavailability). Our team sees this pattern repeatedly: patients convince themselves the compound 'doesn't work' when the real problem is they stored the vial on a bathroom counter instead of in the refrigerator, denaturing the peptide within 48 hours.

The Clinical Truth About Sermorelin Dosing

Here's the honest answer: sermorelin isn't a 'set it and forget it' peptide like semaglutide or tirzepatide. It requires nightly injections, precise meal-to-injection timing, and refrigerated storage discipline that most people underestimate until they're three weeks into a protocol with zero results and realising they've been storing lyophilised powder at room temperature. The peptide works. The 1997 Corpas trial and dozens of follow-up studies confirm sustained IGF-1 elevation and measurable body composition changes. But only if you execute the protocol exactly as prescribed. Skipping two nights a week, injecting an hour after a large dinner, or reconstituting with sterile water instead of bacteriostatic water all produce the same outcome: you're injecting an inactive compound and wondering why your IGF-1 labs haven't budged.

The other truth: sermorelin is not a weight loss medication. It doesn't suppress appetite, slow gastric emptying, or alter satiety signaling the way GLP-1 agonists do. What it does. When dosed correctly. Is improve recovery, support lean mass retention during caloric deficit, and optimise sleep quality by amplifying the GH pulse that naturally promotes slow-wave sleep. Those effects compound over months, not days, and they require structured training and nutrition to manifest as visible body composition change. Patients who approach sermorelin expecting rapid fat loss comparable to tirzepatide are setting themselves up for disappointment.

Most patients see measurable IGF-1 elevation within four to six weeks at 300–500 mcg nightly. Subjective improvements. Deeper sleep, faster post-workout recovery, improved skin elasticity. Typically emerge at 8–12 weeks. Body composition changes (increased lean mass, modest fat reduction) become visible at 16–20 weeks in patients maintaining structured resistance training and adequate protein intake. If you're not seeing lab or subjective response by week six, the protocol execution is wrong. Not the peptide.

Dosing sermorelin correctly means treating it as seriously as you would any prescription medication that requires refrigeration, sterile reconstitution, and time-sensitive administration. It works when the conditions are met. It fails when they're not. There's no middle ground.

If sermorelin's nightly injection schedule feels overwhelming, GLP-1 medications like semaglutide and tirzepatide offer weekly dosing with direct appetite suppression and more predictable weight loss outcomes. Our team at TrimRx provides medically-supervised GLP-1 therapy with prescriber oversight, lab monitoring, and support throughout titration. Sermorelin has its place in metabolic optimisation protocols. But for patients whose primary goal is weight reduction with minimal injection frequency, GLP-1 agonists consistently deliver stronger results with better adherence. You can start your treatment now with full prescriber consultation and medication delivered to your door.